THURSDAY, Dec. 29, 2022 (HealthDay News) — The U.S. Food and Drug Administration’s approval process for the controversial Alzheimer’s drug Aduhelm was “rife with irregularities,” despite lingering doubts about the power of the pricey medication to slow the disease down, a Congressional report released Thursday claims. Actions the agency tookContinue Reading

THURSDAY, Dec. 29, 2022 (HealthDay News) — Adding climate-impact labeling to fast-food menus can have a big effect on whether or not consumers go “green” when eating out, new research suggests. The finding is based on an online survey that asked consumers to order virtual meals after randomly looking overContinue Reading

WEDNESDAY, Dec. 28, 2022 (HealthDay News) — For people with heart disease, new research suggests loneliness, social isolation and living alone can shave years off your life. This trio puts people with established cardiovascular disease at greater risk of premature death, according to the international study. Cardiovascular disease refers toContinue Reading

WEDNESDAY, Dec. 28, 2022 (HealthDay News) — U.S. communities with higher Hispanic, American Indian or Black populations also have the highest concentrations of metal in public water systems, new research reveals. Researchers from Columbia University Mailman School of Public Health in New York City found significantly higher arsenic and uraniumContinue Reading

TUESDAY, Dec. 27, 2022 (HealthDay News) — Living in an area with easy access to parks and rivers appears to slow the progression of devastating neurological diseases, such as Alzheimer’s and Parkinson’s. That’s the conclusion of a new study based on more than a decade and a half tracking diseaseContinue Reading